BRIEF-TRACON Pharmaceuticals Announces $38.7 Million Private Placement [Reuters]
TRACON Pharmaceuticals, Inc. (TCON)
Last tracon pharmaceuticals, inc. earnings: 2/27 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
traconpharma.com
Company Research
Source: Reuters
BRIEF-TRACON Pharmaceuticals Announces $38.7 Million Private Placement | Reuters Reuters Staff 1 Min Read March 23 (Reuters) - Tracon Pharmaceuticals Inc: * TRACON PHARMACEUTICALS ANNOUNCES $38.7 MILLION PRIVATE PLACEMENT * TRACON PHARMACEUTICALS - FINANCING LED BY PUISSANCE CAPITAL MANAGEMENT, PARTICIPATION FROM NEW ENTERPRISE ASSOCIATES, 683 CAPITAL PARTNERS, OTHERS * TRACON PHARMACEUTICALS -? EXPECTS TO APPOINT TED WANG, CHIEF INVESTMENT OFFICER OF PUISSANCE CAPITAL MANAGEMENT TO BOARD FOLLOWING CLOSE * TRACON PHARMACEUTICALS INC - ? TO USE PROCEEDS TO FUND DEVELOPMENT OF TRC105, TO CONTINUE DEVELOPMENT OF OTHER ASSETS SUCH AS TRC253? Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2018 Reuters. All Rights Reserved.
Show less
Read more
Impact Snapshot
Event Time:
TCON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TCON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TCON alerts
High impacting TRACON Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
TCON
News
- TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.MarketBeat
- TRACON Pharmaceuticals Announces Reverse Stock SplitGlobeNewswire
- TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.MarketBeat
- TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) had its price target lowered by analysts at HC Wainwright from $6.00 to $3.00. They now have a "buy" rating on the stock.MarketBeat
- TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned [Yahoo! Finance]Yahoo! Finance
TCON
Earnings
- 3/5/24 - Beat
TCON
Sec Filings
- 4/12/24 - Form S-1
- 4/12/24 - Form 8-K
- 4/12/24 - Form 424B5
- TCON's page on the SEC website